Uptal Patel

Uptal Patel

Company: AstraZeneca

Job title: Head of Early Clinical Renal, CVRM

Seminars:

Chair’s closing remarks 5:30 pm

Read more

day: Day Two

Navigating Combination Therapies for Kidney Diseases 11:30 am

Why should we develop drug combinations? Scientific basis and approaches to identifying synergistic combinations Regulatory considerations for developing drug combinations Clinical development strategies: past, present, and futureRead more

day: Track 2 - Day 2 AM

Panel Discussion: Identifying & Validating a Novel Therapy to Complement SGLT2 Inhibitors 9:30 am

Defining the next wave of therapeutics discovery after SGLT2i to improve clinical outcomes Measuring incremental benefit of novel therapeutics in addition to SGLT2 inhibitors Optimizing a smart preclinical screening platform to monitor efficacy in addition to standard of care Considering innovative trial design and untraditional endpoints to demonstrate efficacy and meet regulatory requirementsRead more

day: Day Two

Chair’s Opening Remarks 8:25 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.